News On Acasti Pharma Inc. (ACST) Now Under GRCE

Dow JonesOct 29 05:08

Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.

GlobeNewswireOct 25 20:00

Acasti Announces Corporate Name Change to Grace Therapeutics

Dow JonesOct 25 20:00

Acasti Pharma's Strategic Moves and Shareholder Decisions

TipRanksOct 1 04:57

Acasti Pharma Analyst Ratings

BenzingaSep 27 00:11 · Ratings

Craig-Hallum Maintains Acasti Pharma(ACST.US) With Buy Rating, Announces Target Price $8

Futu NewsSep 26 21:32 · Ratings